Hettinger, Julia
Alnylam Pharmaceuticals (United States)
3 papers on CoChatORCID 0000-0002-1024-0732
Most cited papers
- Verified
Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
Maier, M. A., Jayaraman, M., Matsuda, S., Liu, J., Barros, S., Querbes, W., Tam, Y. K., Ansell, S. M., Kumar, V., Qin, J., et al. (2013) · Molecular Therapy
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 625
- Verified
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
Dong, Y., Love, K. T., Dorkin, J. R., Sirirungruang, S., Zhang, Y., Chen, D., Bogorad, R. L., Yin, H., Chen, Y., Vegas, A. J., et al. (2014) · Proceedings of the National Academy of Sciences
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 488
- Verified
An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe−/− mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia
Schmidt, P. J., Toudjarska, I., Sendamarai, A. K., Racie, T., Milstein, S., Bettencourt, B. R., Hettinger, J., Bumcrot, D., & Fleming, M. D. (2013) · Blood
Iron Metabolism and DisordersHemoglobinopathies and Related Disorders
Cited by 204
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free